"Coumarins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid.
| Descriptor ID |
D003374
|
| MeSH Number(s) |
D03.383.663.283.446 D03.633.100.150.446
|
| Concept/Terms |
Coumarins- Coumarins
- Coumarines
- 1,2-Benzopyrone Derviatives
- 1,2 Benzopyrone Derviatives
- Derviatives, 1,2-Benzopyrone
- Benzopyran-2-ones
- Benzopyran 2 ones
- Coumarin Derivatives
- Derivatives, Coumarin
- 1,2-Benzopyrones
- 1,2 Benzopyrones
- 1,2-Benzo-Pyrones
- 1,2 Benzo Pyrones
|
Below are MeSH descriptors whose meaning is more general than "Coumarins".
Below are MeSH descriptors whose meaning is more specific than "Coumarins".
This graph shows the total number of publications written about "Coumarins" by people in this website by year, and whether "Coumarins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2008 | 2 | 0 | 2 |
| 2010 | 2 | 1 | 3 |
| 2011 | 3 | 1 | 4 |
| 2012 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
| 2015 | 3 | 0 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 2 | 0 | 2 |
| 2018 | 3 | 0 | 3 |
| 2019 | 2 | 1 | 3 |
| 2022 | 1 | 1 | 2 |
| 2023 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Coumarins" by people in Profiles.
-
Karumuru V, Dhasmana A, Mamidi N, Chauhan SC, Yallapu MM. Unveiling the potential of Urolithin A in Cancer Therapy: Mechanistic Insights to Future Perspectives of Nanomedicine. Nanotheranostics. 2025; 9(2):121-143.
-
Aghimien MO, Kolawole Q, Igbinoba PO, Musa MA, Latinwo L. Non-cytotoxic 3-Acetylcoumarin as an Attractive Target for Human Monoamine Oxidase (HMAO) Enzymes. Anticancer Res. 2024 Jun; 44(6):2335-2341.
-
Musa MA, Kolawole Q. 7,8-Diacetoxy-3-(4-methylsulfonylphenyl)-4-phenylcoumarin Induces ROS-dependent Cell Death in the A549 Human Lung Cancer Cell Line. Anticancer Res. 2023 Mar; 43(3):1001-1007.
-
Mesas C, Garc?s V, Mart?nez R, Ortiz R, Doello K, Dominguez-Vera JM, Berm?dez F, Porres JM, L?pez-Jurado M, Melguizo C, Delgado-L?pez JM, Prados J. Colon cancer therapy with calcium phosphate nanoparticles loading bioactive compounds from Euphorbia lathyris: In vitro and in vivo assay. Biomed Pharmacother. 2022 Nov; 155:113723.
-
Liu F, Mallick S, O'Donnell TJ, Rouzimaimaiti R, Luo Y, Sun R, Wall M, Wongwiwatthananukit S, Date A, Silva DK, Williams PG, Chang LC. Coumarinolignans with Reactive Oxygen Species (ROS) and NF-?B Inhibitory Activities from the Roots of Waltheria indica. Molecules. 2022 May 19; 27(10).
-
Kutlehria S, Bagde A, Patel N, Singh M. Whole-Eye Perfusion Model for Screening of the Ocular Formulations via Confocal Laser Scanning Microscopy. AAPS PharmSciTech. 2019 Sep 12; 20(7):307.
-
Foroozesh M, Sridhar J, Goyal N, Liu J. Coumarins and P450s, Studies Reported to-Date. Molecules. 2019 Apr 24; 24(8).
-
Singh R, Chandrashekharappa S, Bodduluri SR, Baby BV, Hegde B, Kotla NG, Hiwale AA, Saiyed T, Patel P, Vijay-Kumar M, Langille MGI, Douglas GM, Cheng X, Rouchka EC, Waigel SJ, Dryden GW, Alatassi H, Zhang HG, Haribabu B, Vemula PK, Jala VR. Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway. Nat Commun. 2019 01 09; 10(1):89.
-
Musa MA, Badisa VLD, Latinwo LM, Ntantie E. 7,8-Dihydroxy-3-arylcoumarin Induces Cell Death Through S-Phase Arrest in MDA-MB-231 Breast Cancer Cells. Anticancer Res. 2018 Nov; 38(11):6091-6098.
-
Musa MA, Gbadebo AJ, Latinwo LM, Badisa VL. 7,8-Dihydroxy-3-(4-nitrophenyl)coumarin induces cell death via reactive oxygen species-independent S-phase cell arrest. J Biochem Mol Toxicol. 2018 Dec; 32(12):e22203.